Cargando…
Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration
Following the widespread use of anti SARS-CoV-2 vaccines, there have been reports of thrombocytopenia developing after the administration of different types of vaccine. We report a case of a 63-year-old male who developed neurological symptoms after receiving the second dose of the bnt162b2 vaccine....
Autores principales: | Fenoglio, Roberta, Marchisio, Martina, Baffa, Alessandra, Quattrocchio, Giacomo, Roccatello, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440330/ https://www.ncbi.nlm.nih.gov/pubmed/36057036 http://dx.doi.org/10.1007/s40620-022-01402-0 |
Ejemplares similares
-
Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine
por: Güney, Tekin, et al.
Publicado: (2022) -
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021) -
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
por: Ruhe, Johannes, et al.
Publicado: (2021) -
Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient
por: Yoshida, Kikuaki, et al.
Publicado: (2021) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)